Vivos Therapeutics, Inc. (VVOS)
USD 2.61
(1.56%)
USD 2.61
(1.56%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 10.73 Million USD | -21.79% |
| 2022 | 13.72 Million USD | -59.27% |
| 2021 | 33.68 Million USD | 33.01% |
| 2020 | 25.32 Million USD | 235.39% |
| 2019 | 7.55 Million USD | -7.95% |
| 2018 | 8.2 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 15.84 Million USD | 34.21% |
| 2024 Q1 | 11.8 Million USD | 10.01% |
| 2023 Q1 | 17.1 Million USD | 24.64% |
| 2023 Q2 | 13.74 Million USD | -19.6% |
| 2023 FY | 10.73 Million USD | -21.79% |
| 2023 Q4 | 10.73 Million USD | 4.0% |
| 2023 Q3 | 10.31 Million USD | -24.96% |
| 2022 Q1 | 29.55 Million USD | -12.27% |
| 2022 FY | 13.72 Million USD | -59.27% |
| 2022 Q4 | 13.72 Million USD | -25.43% |
| 2022 Q3 | 18.4 Million USD | -24.51% |
| 2022 Q2 | 24.37 Million USD | -17.53% |
| 2021 Q2 | 46.15 Million USD | 110.24% |
| 2021 FY | 33.68 Million USD | 33.01% |
| 2021 Q4 | 33.68 Million USD | -17.88% |
| 2021 Q3 | 41.02 Million USD | -11.12% |
| 2021 Q1 | 21.95 Million USD | -13.32% |
| 2020 FY | 25.32 Million USD | 235.39% |
| 2020 Q3 | 8.48 Million USD | 23.04% |
| 2020 Q2 | 6.89 Million USD | 0.0% |
| 2020 Q1 | - USD | -100.0% |
| 2020 Q4 | 25.32 Million USD | 198.53% |
| 2019 Q4 | 7.55 Million USD | 0.0% |
| 2019 FY | 7.55 Million USD | -7.95% |
| 2018 FY | 8.2 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | 65.791% |
| BrainsWay Ltd. | 62.97 Million USD | 82.961% |
| Cerus Corporation | 197.74 Million USD | 94.574% |
| Envoy Medical, Inc. | 7.64 Million USD | -40.445% |
| electroCore, Inc. | 16.38 Million USD | 34.521% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -39.496% |
| IceCure Medical Ltd | 16.41 Million USD | 34.613% |
| Inogen, Inc. | 326.19 Million USD | 96.711% |
| OrthoPediatrics Corp. | 449.58 Million USD | 97.613% |
| Lucid Diagnostics Inc. | 27.27 Million USD | 60.653% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | 35.28% |
| MaxCyte, Inc. | 268.27 Million USD | 96.0% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -32.513% |
| Nexalin Technology, Inc. | 3.63 Million USD | -195.436% |
| Orthofix Medical Inc. | 925.31 Million USD | 98.84% |
| PAVmed Inc | 33.11 Million USD | 67.602% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 92.52% |
| RxSight, Inc. | 182.55 Million USD | 94.122% |
| Sight Sciences, Inc. | 166.65 Million USD | 93.561% |
| SI-BONE, Inc. | 230.42 Million USD | 95.343% |
| TELA Bio, Inc. | 78.04 Million USD | 86.252% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 95.74% |
| Acutus Medical, Inc. | 53.96 Million USD | 80.115% |
| Talis Biomedical Corporation | 98.34 Million USD | 89.089% |
| Spectral AI, Inc. | 10.69 Million USD | -0.355% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 95.093% |
| CVRx, Inc. | 115.22 Million USD | 90.688% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 81.708% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -244.434% |
| Bioventus Inc. | 810.91 Million USD | 98.677% |
| Venus Concept Inc. | 93.65 Million USD | 88.543% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | 58.29% |
| LivaNova PLC | 2.42 Billion USD | 99.558% |
| 908 Devices Inc. | 202.98 Million USD | 94.714% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 98.667% |
| Nemaura Medical Inc. | 14.56 Million USD | 26.321% |
| NeuroPace, Inc. | 107.65 Million USD | 90.033% |
| LENSAR, Inc. | 69.58 Million USD | 84.58% |
| Apyx Medical Corporation | 79.24 Million USD | 86.459% |
| Cutera, Inc. | 346.29 Million USD | 96.901% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | 74.462% |
| BioSig Technologies, Inc. | 1.79 Million USD | -496.774% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 96.035% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | 74.848% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 99.716% |
| Axonics, Inc. | 719.92 Million USD | 98.51% |
| Outset Medical, Inc. | 313.8 Million USD | 96.581% |
| IRIDEX Corporation | 34.43 Million USD | 68.841% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 97.349% |
| IRadimed Corporation | 92.15 Million USD | 88.357% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -104.225% |
| INVO Bioscience, Inc. | 20.88 Million USD | 48.63% |
| Telesis Bio, Inc. | 70.41 Million USD | 84.761% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 93.037% |
| Varex Imaging Corporation | 1.24 Billion USD | 99.141% |
| Quipt Home Medical Corp. | 247.4 Million USD | 95.663% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -15.252% |
| Pulmonx Corporation | 178.95 Million USD | 94.004% |
| Dynatronics Corporation | 25.94 Million USD | 58.636% |
| Modular Medical, Inc. | 13.8 Million USD | 22.286% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -0.028% |
| Semler Scientific, Inc. | 78.06 Million USD | 86.255% |
| InMode Ltd. | 863.28 Million USD | 98.757% |
| Bruker Corporation | 4.24 Billion USD | 99.748% |
| Cytosorbents Corporation | 53.26 Million USD | 79.854% |
| DexCom, Inc. | 6.26 Billion USD | 99.829% |
| Align Technology, Inc. | 6.08 Billion USD | 99.824% |
| Viveve Medical, Inc. | 25.91 Million USD | 58.592% |
| ZimVie Inc. | 1.2 Billion USD | 99.11% |
| Movano Inc. | 9.42 Million USD | -13.894% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 97.844% |
| Nexalin Technology, Inc. | 3.63 Million USD | -195.436% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 81.708% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 98.874% |
| Profound Medical Corp. | 43.68 Million USD | 75.439% |
| Insulet Corporation | 2.58 Billion USD | 99.585% |
| enVVeno Medical Corporation | 48.63 Million USD | 77.938% |
| Surmodics, Inc. | 185.73 Million USD | 94.223% |
| iCAD, Inc. | 41.41 Million USD | 74.093% |
| Nuwellis, Inc. | 9.77 Million USD | -9.826% |
| Biotricity, Inc. | 5.94 Million USD | -80.56% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 97.523% |
| Aethlon Medical, Inc. | 8.24 Million USD | -30.124% |
| InspireMD, Inc. | 47.64 Million USD | 77.478% |
| PAVmed Inc. | 33.11 Million USD | 67.602% |
| BIOLASE, Inc. | 35.1 Million USD | 69.431% |
| Beyond Air, Inc. | 56.96 Million USD | 81.163% |
| FONAR Corporation | 214.24 Million USD | 94.992% |
| AxoGen, Inc. | 196.82 Million USD | 94.549% |
| Vivani Medical, Inc. | 45.79 Million USD | 76.571% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 96.187% |
| Inari Medical, Inc. | 674.23 Million USD | 98.409% |
| UFP Technologies, Inc. | 404.13 Million USD | 97.345% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | 54.142% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -12.91% |
| Tenon Medical, Inc. | 6.34 Million USD | -69.11% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -14.064% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 89.648% |
| AdaptHealth Corp. | 4.61 Billion USD | 99.768% |
| Sintx Technologies, Inc. | 15.36 Million USD | 30.166% |
| NanoVibronix, Inc. | 6.67 Million USD | -60.773% |
| Quanterix Corporation | 425.01 Million USD | 97.475% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -15.252% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 80.029% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 99.385% |
| TransMedics Group, Inc. | 706.04 Million USD | 98.48% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 83.02% |
| NeuroMetrix, Inc. | 21.42 Million USD | 49.917% |
| Hyperfine, Inc. | 94.19 Million USD | 88.609% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 96.006% |
| Biomerica, Inc. | 9.25 Million USD | -15.95% |
| Bone Biologics Corporation | 3.73 Million USD | -187.07% |
| AVITA Medical, Inc. | 144.33 Million USD | 92.566% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -120.395% |
| Silk Road Medical, Inc | 265.3 Million USD | 95.956% |